Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Health Economic Evaluations of Cancer in Brazil: A Systematic Review

Texto completo
Autor(es):
Campolina, Alessandro G. [1, 2, 3] ; Yuba, Tania Y. [4] ; Decimoni, Tassia C. [4] ; Leandro, Roseli [4] ; Estevez Diz, Maria del Pilar [2] ; Novaes, Hillegonda M. D. [4, 3] ; de Soarez, Patricia C. [4, 3]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Inst Canc Estado Sao Paulo, Sao Paulo - Brazil
[2] Inst Canc Estado Sao Paulo, Dept Oncol, Sao Paulo - Brazil
[3] Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS - Brazil
[4] Univ Sao Paulo, Fac Med, Prevent Med, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo de Revisão
Fonte: FRONTIERS IN PUBLIC HEALTH; v. 6, JUL 27 2018.
Citações Web of Science: 1
Resumo

Background: A large number of health economic evaluation (HEE) studies have been published in developed countries. However, Brazilian HEE literature in oncology has not been studied. Objective: To investigate whether the scientific literature has provided a set of HEE in oncology capable of supporting decision making in the Brazilian context. Methods: A systematic review was conducted to identify and characterize studies in this field. We searched multiple databases selecting partial and full HEE studies in oncology (1998-2013). Results: Fifty-five articles were reviewed, of these, 33 (60%) were full health economic evaluations. Type of cancers most frequently studied were: breast (38.2%), cervical (14.6%), lung (10.9%) and colorectal (9.1%). Procedures (47.3%) were the technologies most frequently evaluated. In terms of the intended purposes of the technologies, most (63.6%) were treatments. The majority of the incremental cost-effectiveness ratios (ICERs) reported have been below the cost-effectiveness threshold suggested by the World Health Organization (WHO). Conclusions: There has been an increase in the number of HEEs related to cancer in Brazil. These studies may support decision-making processes regarding the coverage of and reimbursement of healthcare technologies for cancer treatment in Brazil. (AU)

Processo FAPESP: 12/22126-3 - Revisão sistemática dos estudos de avaliação econômica desenvolvidos no Brasil de 1980-2012
Beneficiário:Patricia Coelho de Soárez
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 15/02713-0 - Políticas de incorporação de tecnologias no Sistema Único de Saúde no Brasil: utilização do limiar de custo-efetividade nas avaliações econômicas nacionais
Beneficiário:Tania Yuka Yuba
Modalidade de apoio: Bolsas no Brasil - Doutorado